Alira Health welcomes Mark Kasakevich as Senior Vice President, U.S. Pharma

Mark Kasakevich joins Alira Health as Senior Vice President, U.S. Pharma

BOSTON, USA – Alira Health (, a leading international healthcare and life sciences advisory firm, announced that Mark Kasakevich, PhD has joined the firm as Senior Vice President, U.S. Pharma. Mark brings an extensive background in pharmaceuticals, strategic planning, and product launches and is based out of Alira Health’s Framingham, Massachusetts headquarters.

“Mark is a perfect match for Alira Health’s collaborative culture, and he brings years of invaluable expertise in pharma consulting services, a strong track record in delivering value to hundreds of clients, and a humble and very powerful coaching and mentoring mindset with his colleagues,” said Gabriele Brambilla, Alira Health’s Chief Executive Officer.

“I chose Alira Health because of the opportunity to help a dynamic and growing organization to expand its consulting footprint in U.S. pharma and biotech,” said Dr. Kasakevich. “This opportunity was particularly attractive given the ability to access its diverse internal capabilities in areas mirroring critical pharma company activities. This provides a platform for meaningful differentiation from other consultancies as we synthesize solutions to customer challenges. I am also excited to help further develop our downstream consulting business in addition to our current focus on early-stage global work.”

Dr. Kasakevich brings over 25 years of multi-functional operational and international experience in pharmaceuticals, diagnostics, and chemicals. He has an extensive background in forming, facilitating, and leading cross-functional teams focused on strategic planning, pharmaceutical product launch, operational improvements, and competitive preparedness. Mark’s previous clients include Leo, Janssen Oncology, Celgene, Dicerna, and Abbvie.

To learn more about the Alira Health team, please visit